BBHC
KMTS

Brown Brothers Harriman & Co’s Kestra Medical Technologies KMTS Stock Holding History

Brown Brothers Harriman & Co’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$61.9K Hold
3,104
– – ﹤0.01% 1018
2025
Q4 		$82.3K Hold
3,104
– – ﹤0.01% 943
2025
Q3 		$73.8K Buy
3,104
+656
+27% +$11.7K ﹤0.01% 936
2025
Q2 		$40.6K Buy
2,448
+1,973
+415% +$43.1K ﹤0.01% 970
2025
Q1 		$11.8K Buy
+475
New +$10.9K ﹤0.01% 1042

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AP
Andera Partners Paris $177M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Brown Brothers Harriman & Co's KMTS Position: Q1 2026 in Review

Brown Brothers Harriman & Co held its Kestra Medical Technologies (KMTS) position steady in Q1 2026 at 3,104 shares worth $61.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1018.

Brown Brothers Harriman & Co first reported a position in KMTS in Q1 2025 and has held it in 5 quarters since. The position peaked at $82.3K in Q4 2025. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • Brown Brothers Harriman & Co held 3,104 shares of Kestra Medical Technologies worth $61.9K as of Q1 2026.
  • Brown Brothers Harriman & Co left its Kestra Medical Technologies share count unchanged in Q1 2026.
  • Kestra Medical Technologies made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q1 2026, its #1018 holding.
  • Brown Brothers Harriman & Co first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 5 quarters since.
  • Brown Brothers Harriman & Co's Kestra Medical Technologies position peaked at $82.3K in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q1 2026, filed 14 May 2026.